Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

DeviceTalks Podcast Network

Edwards’ Joe Nuzzolese on planning for disruption, prioritizing patients & automating supply chains

15 Apr 2025

Description

In this episode of Structural Heart Talks, Joe Nuzzolese, corporate VP of global supply chain and quality at Edwards Lifesciences, shares how the company has built a resilient and responsive supply chain capable of withstanding significant disruptions—pandemic included—without missing a single patient case. Nuzzolese explains how Edwards takes a "plan, make, source, deliver" approach, and why MedTech supply chains differ from consumer goods with a stronger emphasis on quality and availability. He details how the company strategically leverages dual sourcing, inventory buffering, and global distribution flexibility to maintain operations, even when borders close or suppliers face challenges. He also unpacks the need for automation and digital integration, explains how Edwards connects employees to patient outcomes to instill purpose, and reveals why fostering innovation readiness is central to their long-term strategy. Thank you to Daikin America for sponsoring this episode of Structural Heart Talks. To learn more about Daikin America’s products for your medical application visit https://daikin-america.com. Wait, there’s more! Want to learn more about Daikin America’s new Co-Extrusion technology? Click here for a high resolution image with more detail. Thank you for listening to the Structural Heart Talks podcast.  Subscribe to Structural Heart Talks or the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks on YouTube Podcasts to ensure you never miss an episode.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.